Austar Lifesciences Limited (Stock Code: 06118) released its monthly return for the period ended 31 October 2025, indicating no changes in its authorized or issued share capital. The total authorized share capital remained at HKD 100,000,000, represented by 10,000,000,000 ordinary shares at a par value of HKD 0.01 each.

The company’s issued share capital also remained steady at 512,582,000 ordinary shares with no treasury shares. The announcement was submitted on 03 November 2025, and no further alterations or transactions were reported.